Sn | Catalog | Target name | Area | Reactivity | App |
1 | IR3-8 | GAPDH | Loading control | H,M,R | WB, IF, IHC |
2 | IR8-23 | Nestin / NES | Neuroscience | H,M,R | WB, IF, IHC |
3 | IR13-36 | AIF / Iba1 | Neuroscience | H,M,R | WB, IF, IHC-P, IHC(Fr) |
4 | IR5-11 | Lamin B1 | Loading control | H,M,R | WB, IF |
5 | IR7-21 | NOTCH1 | Neuroscience | H,M,R | WB, IF |
6 | IR11-31 | Beta Tubulin 3 / Tuj1 | Neuroscience | H,M,R | WB, IF, IHC |
7 | IR12-33 | MAP2 | Neuroscience | H,M,R | WB, IF, IHC |
8 | IR1-2 | Beta-tubulin | Loading control | H,M,R | WB, IF |
9 | IR4-10 | Histone H3 | Loading control | H,M,R | WB, IF, IHC |
10 | IR14-38 | BDNF | Neuroscience | H,M,R | WB, IF, IHC |
11 | IR15-44 | GFAP | Neuroscience | H,M,R | WB, IF, IHC(Fr) |
12 | IR1-2-2 | Vinculin | Loading control | H,M,R | WB, IF |
13 | IR21-57 | NF-H / neurofilament | Neuroscience | H,M,R | WB, IF, IHC-P, IHC(Fr) |
14 | IR43-128 | Alpha-synuclein | Neuroscience | H,M,R | WB, IF, IHC(Fr) |
15 | IR11-26 | SOX2 | Neuroscience | H,M,R | WB, IF, IHC(Fr) |
16 | IR38-119 | LRRK2 | Neuroscience | H,M,R | WB, IF |
17 | IR44-131 | Huntingtin | Neuroscience | H,M,R | WB, IF |
18 | IR39-123 | MAPT / Tau | Neuroscience | H,M,R | WB, IF, IHC-P, IHC(Fr) |
19 | IR45-137 | Vimentin | EMT | H,M,R | WB, IF, IHC, IP |
20 | IR49-149 | beta-catenin | EMT | H,M,R | WB, IF, IHC |
21 | IR55-179 | E-cadherin (Extracellular) | EMT | H | WB, IF, IHC |
22 | IR46-143 | N-Cadherin | EMT | H,M,R | WB, IF, IHC, FC |
23 | IR48-147 | Fibronectin | EMT | H,M,R | WB, IF, IHC |
24 | IR94-392 | BCL2 | Apoptosis | H,M,R | WB, IF, IHC |
25 | IR75-257 | CD31 / PECAM1 | Endothelial marker | H | WB, IHC |
26 | IR84-366 | LC3B | Autophagy | H,M,R | WB, IF, IHC |
27 | IR101-420 | PARP1 cleaved Asp214 | Apoptosis / Caspase | H,M,R | WB, IF, IHC |
28 | IR171-666 | Akt1+2+3 | Signaling | H,M,R | WB, IF |
29 | IR115-286 | Cyclin A2 | Cell cycle | H,M | WB, IF, IHC |
30 | IR187-705 | ERK1+2 | Signaling | H,M,R | WB, IF |
31 | IR2-7 | Beta-actin | Loading control | H,M,R | WB, IF, IHC |
32 | IR70-234 | MMP9 | MMP remodeling | H | WB, IF, IHC |
33 | IR99-409 | Caspase-8 | Apoptosis/Caspase | H | WB, IF, IHC |
34 | IR109-446 | COX2 / PTGS2 | Angiogenesis factor | H,M,R | WB, IF, IHC |
35 | IR114-473 | IL-1 beta | Angiogenesis factor | H,M,R | WB, IF |
36 | IR67-227 | MMP2 | MMP remodeling | H,M,R | WB, IF, IHC |
37 | IR66-225 | MMP1 | MMP remodeling | H, R | WB, IF |
38 | IR71-245 | MMP14 / MT1-MMP | MMP remodeling | H,M,R | WB, IF, IHC |
39 | IR95-397 | Caspase-1 Cleaved Asp297 | Apoptosis / Caspase | H | WB, IF |
40 | IR108-442 | VEGF | Angiogenesis factor | H,M,R | WB, IF, IHC |
41 | IR116-289 | Cyclin B1 | Cell cycle | H | WB, IF, IHC |
42 | IR117-294 | Cyclin D1 | Cell cycle | H,M,R | WB, IF, IHC |
43 | IR58-200 | FAK / PTK2 | Focal adhesion | H,M,R | WB, IF, IHC |
44 | IR60-205 | Paxillin | Focal adhesion | H,M,R | WB, IF, IHC |
45 | IR122-312 | p21 Waf1 / Cip1 | Cell cycle | H,M,R | WB, IF, IHC |
46 | IR123-314 | p27 Kip1 | Cell cycle | H | WB, IF |
47 | IR56-184 | ZO-1 / TJP1 | EMT | H,M,R | WB, IF, IHC |
48 | IR76-259 | CD34 | Endothelial marker | H,M,R | WB, IF, IHC |
49 | IR78-268 | ICAM-1 / CD54 | Endothelial marker | H | WB, IF, IHC |
50 | IR211-769 | EGFR | Cancer marker | H,M,R | WB, IF, IHC |
51 | IR210-763 | HER2 / ERBB2 | Cancer Biomarker | H,M,R | WB, IF, IHC |
52 | IR208-752 | CD44 | Cancer Stem Cell | H,M,R | WB, IF, IHC |
53 | IR218-1 | EpCAM (Intracellular) | Cancer Biomarker / EMT | H,M,R | WB, IF, IHC |
54 | IR79-272 | VCAM-1 / CD106 | Endothelial marker | H,M | WB, IF, IHC |
55 | IR127-515 | IRE1α / ERN1 | ER stress | H,M,R | WB, IF |
56 | IR133-535 | eIF2α / EIF2S1 | ER stress | H, R | WB, IF |
57 | IR205-742 | p63 | Cancer Biomarker | H,M,R | WB, IF, IHC |
58 | IR68-229 | MMP3 | MMP remodeling | H | WB, IF |
59 | IR72-249 | TIMP1 | MMP remodeling | H,M,R | WB, IF, IHC |
60 | IR136-543 | NFE2L2 / NRF2 | ER stress | H,M,R | WB, IF, IHC |
61 | IR213-777 | ESR1 / Estrogen receptor alpha | Cancer Biomarker | H,M,R | WB, IHC |
62 | IR219-807 | MET / C-MET / HGFR | Cancer Biomarker | H,M,R | WB, IF, IHC |
63 | IR112-457 | TGF beta 1 | Angiogenesis factor | H,M,R | WB, IF, IHC |
64 | IR113-466 | HIF1A / HIF-1 alpha | Angiogenesis factor | H,M,R | WB, IF |
65 | IR47-146 | α-Smooth Muscle Actin | EMT | H,M,R | WB, IF, IHC |
66 | IR91-384 | SQSTM1 / P62 | Autophagy | H,M,R | WB, IF, IHC |
67 | IR215-787 | PGR / Progesterone Receptor | Cancer Biomarker | H,M,R | WB, IHC |
68 | IR231-856 | iNOS / NOS2 | Inflammation | H,M,R | WB, IF, IHC |
69 | IR226-865 | Cytokeratin 5/6, CK5/6 | Cancer Biomarker | H | WB, IF, IHC |
70 | IR228-868 | Cytokeratin 7, CK7 | Cancer Biomarker | H | WB, IF, IHC |
71 | IR235-880 | Cytokeratin 14/17, CK14/17 | Cancer Biomarker | H | WB, IF, IHC |
72 | IR236-890 | Cytokeratin 18/19, CK18/19 | Cancer Biomarker | H | WB, IF, IHC |
73 | IR238-892 | Cytokeratin 20, CK20 | Cancer Biomarker | H | WB, IF, IHC |
74 | IR222-861 | Pan-Cytokeratin, Pan-CK | Cancer Biomarker | H | WB, IF, IHC |
75 | IR81-279 | VEGFR2 / KDR / CD309 | Angiogenesis factor | H,M,R | WB, IF, IHC |
76 | IR212-772 | KI-67 / MKI67 | Cancer Biomarker | H | WB, IF, IHC |
77 | IR222-861-FITC | Pan-Cytokeratin, Pan-CK, FITC conjugate | Cancer Biomarker | H | CTC, IF, FC |
78 | IR55-180 | E-cadherin (Intracellular specific) | EMT | H,M | WB, IF, IHC |
79 | IR93-390 | BAX | Apoptosis | H,M,R | WB, IF, IHC |
80 | IR188-706 | Phospho ERK1+2 (Thr202/Tyr204) | Signaling | H,M,R | WB |
81 | IR50-154 | SNAIL | EMT | H,M | WB |
82 | IR105-435 | Cytochrome C / CYCS | Apoptosis / Caspase | H,M,R | WB, IHC |
83 | IR30-78 | CD133 / Prominin-1 (IHC only) | Cancer Stem Cell | H | IHC |
84 | IR239-896 | CD138 / Syndecan-1 (IHC prefer) | Immune cell / MM cell marker | H | WB, IF, IHC |
85 | IR137-549 | NF-κB p65 / RelA | Signaling | H,M | WB |
86 | IR172-668 | Phospho-AKT (Ser473) | Signaling | H,M,R | WB |
87 | IRST002 | EGFR (Extracellular specific) | Cancer Biomarker | H | WB, IHC |
88 | IR77-263 | CD45 (Extracellular specific) | Immune cell / Leukocyte marker | H,M | WB, IF, IHC, FC |
89 | IR77-264 | CD45 (Intracellular specific) | Immune cell / Leukocyte marker | H | WB, IF, IHC, FC |
90 | IR77-263-PE | CD45 (Extracellular), PE conjugate | Immune cell / Leukocyte marker | H,M | CTC, IF, FC |
91 | IR77-264-PE | CD45 (Intracellular), PE conjugate | Immune cell / Leukocyte marker | H | CTC, IF, FC |
92 | IRCP005 | GON4L | Cancer Biomarker | H | WB |
93 | IRST003 | SARS-CoV-2 (COVID-19) Spike | Infectiouse disease | H | WB, IF, Neutralizing |
94 | IRCR007 | SARS-CoV-2 (COVID-19) nucleocapsid | Infectiouse disease | H | WB, IF, Neutralizing |
95 | IR250-898 | CD4 | Immune cell / T cell marker | H | WB, IHC, FC |
96 | IR251-890 | CD8 | Immune cell / T cell marker | H | WB, IHC, FC |
97 | IR252-897 | CD3 | Immune cell / T cell marker | H | WB, IHC, FC |
98 | IR253-901 | CD19 | Immune cell / B cell marker | H | WB, IHC, FC |
99 | IR254-903 | CD16 | Immune cell / NK cell marker | H | IHC, FC |
100 | IR74-P1 | IL-6 | Inflammation | H | WB |
101 | IR30-79 | CD133 / Prominin-1 (Intracellular domain) | Cancer Stem Cell | H,M,R | WB |
102 | IR96-401 | Caspase-3 cleaved p17/19 | Apoptosis | H,M,R | WB |
103 | IR218-3 | EpCAM / CD326 (Extracellular domain) | Cancer Biomarker / EMT | H | WB |
104 | IR100-414 | Caspase-9 cleaved Asp315 | Apoptosis | H | WB |
105 | IR132-533 | ATF6 | ER stress | H,M,R | WB |
106 | IR129-522 | CHOP / GADD153 / DDIT3 | ER stress | H,M,R | WB |
107 | IR135-538 | PERK / EIF2AK3 | ER stress | H,M | WB |
108 | IR53-167 | ZEB1 | EMT | H,M,R | WB |
109 | IR145-580 | IKB alpha / NFKBIA | Signaling | H,M,R | WB |
110 | IR239-895 | CD138 / Syndecan-1 | Immune cell / MM cell marker | H | WB, IF, IHC |
111 | IR300-981 | CD9 | Exosome Biomarker | H,M,R | WB |
112 | IR301-983 | CD63 | Exosome Biomarker | H | WB |
113 | IR303-988 | Alix | Exosome Biomarker | H,M,R | WB |
114 | IR57-193 | OCLN / occludin | EMT | H,M,R | WB |
115 | IR255-907 | CD56 / NCAM1 | Immune cell / NK cell marker | H,M,R | WB |
116 | IR323-1016 | Toll-like Receptor 3 / TLR3 | Innate immune | H,M,R | WB |
117 | IR324-1020 | Toll-like Receptor 4 / TLR4 | Innate immune | H,M,R | WB |
118 | IR218-3-PE | EpCAM (Extracellular), PE conjugate | Cancer Biomarker / EMT | H | CTC, IF, FC |
119 | IR218-3-F647 | EpCAM (Extracellular), HiLyte Fluor647 | Cancer Biomarker / EMT | H | CTC, IF, FC |
120 | IR218-3-Bio | EpCAM (Extracellular), Biotinylated | Cancer Biomarker / EMT | H | CTC |
121 | IR77-263-F647 | CD45 (Extracellular), HiLyte Fluor647 | Immune cell / Leukocyte marker | H,M | CTC, IF, FC |
122 | IR77-264-F647 | CD45 (Intracellular), HiLyte Fluor647 | Immune cell / Leukocyte marker | H | CTC, IF, FC |
123 | IR208-752-F647 | CD44, HiLyte Fluor647 | Cancer Stem Cell | H,M,R | IF, FC |